688363.SH
华熙生物
SSE · Basic Materials · Chemicals - Specialty · CN
CNY 35.33
−2.89%Aug 27, 2026, 11:14 UTC
Bloomage Biotechnology announced its 2026 first-half results: net profit attributable to shareholders was 153 million yuan, down 30.82% year-on-year.
Source:Aug 20, 2026, 07:49 UTC
Bloomage Biotechnology and others established Bloomage ReYouth Life Technology (Beijing) Co., Ltd., whose business scope includes artificial intelligence software development and intelligent robot sales.
Source:Jul 13, 2026, 07:13 UTC
Huaxi Bio established a medical device sales subsidiary in Beijing with registered capital of 5 million yuan.
Source: